GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 743 filers reported holding GLAXOSMITHKLINE PLC in Q2 2016. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $6,000 | +200.0% | 171 | -80.0% | 0.00% | – |
| Q4 2017 | $2,000 | -94.1% | 856 | 0.0% | 0.00% | -100.0% |
| Q3 2017 | $34,000 | -5.6% | 856 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $36,000 | 0.0% | 856 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $36,000 | +12.5% | 856 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $32,000 | -27.3% | 856 | -16.2% | 0.00% | 0.0% |
| Q3 2016 | $44,000 | 0.0% | 1,021 | 0.0% | 0.00% | -33.3% |
| Q2 2016 | $44,000 | +7.3% | 1,021 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $41,000 | 0.0% | 1,021 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $41,000 | +583.3% | 1,021 | +518.8% | 0.00% | – |
| Q3 2015 | $6,000 | 0.0% | 165 | 0.0% | 0.00% | – |
| Q2 2015 | $6,000 | -14.3% | 165 | 0.0% | 0.00% | – |
| Q1 2015 | $7,000 | 0.0% | 165 | 0.0% | 0.00% | – |
| Q4 2014 | $7,000 | -99.6% | 165 | -99.5% | 0.00% | -100.0% |
| Q4 2013 | $1,938,000 | +6.4% | 36,300 | 0.0% | 0.15% | -9.9% |
| Q3 2013 | $1,821,000 | -99.9% | 36,300 | 0.0% | 0.17% | -65.5% |
| Q2 2013 | $1,813,911,000 | – | 36,300 | – | 0.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |